Second primary malignancies among patients with soft tissue tumors in Sweden

International Journal of Cancer

Volumn 119, Issue 4, 2006, Pages 909-914

  Ji, Jianguang ^a   Hemminki, Kari ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Fibrosarcoma; Rhabdomyosarcoma; Second primary malignancies; Soft tissue tumors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; FAMILIAL CANCER; FIBROSARCOMA; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; INFANT; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MELANOMA; MYXOSARCOMA; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RHABDOMYOSARCOMA; RISK ASSESSMENT; SECOND CANCER; SKIN CANCER; SOFT TISSUE TUMOR; SQUAMOUS CELL CARCINOMA; SWEDEN; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SOFT TISSUE NEOPLASMS; SWEDEN;

EID: 33745895282     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21910     Document Type: Article

References (45)

1. Meyer WH, Spunt SL. Soft tissue sarcomas of childhood. Cancer Treat Rev 2004;30:269-80.
2. Center for Epidemiology. Cancer incidence in Sweden 2000. Stockholm: The National Board of Health and Weifware, 2002.
3. Fletcher CD, Rydholm A, Singer S, Sundaran M, Coindre JM. Soft tissue tumors: epidemiology, clinical features, histopathological typing and grading. In: Fletcher CD, Unni KK, Mertens F, eds. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC press, 2002, 12-18.
4. Cooper CS, Stratton MR. Soft tissue tumours: the genetic basis of development. Carcinogenesis 1991;12:155-65.
5. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998;90:1039-71.
6. Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K, Shipley J. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996;56:3220-4.
7. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-52.
8. Malkin D, Li FP, Strong LC, Fraumeni JF, Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
9. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD, Jr. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121-8.
10. Moll AC, Imhof SM, Bouter LM, Tan KE. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 1997;18:27-34.
11. Hisada M, Garber JE, Fung CY, Fraumeni JF, Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-11.
12. Carnevale A, Lieberman E, Cardenas R. Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma. Arch Med Res 1997;28:383-6.
13. Anderson J, Gordon A, Pritchard-Jones K, Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 1999;26:275-85.
14. Weber KL. What's new in musculoskeletal oncology. J Bone Joint Surg Am 2005;87:1400-10.
15. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(Suppl 5):v 128-49.
16. Kaldor J. Second cancer following chemotherapy and radiotherapy. An epidemiological perspective. Acta Oncol 1990;29:647-55.
17. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002;2:124-32.
18. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-29.
19. Merimsky O, Kollender Y, Issakov J, Bickels J, Flusser G, Gutman M, Lev-Chelouche D, Inbar M, Meller I. Multiple primary malignancies in association with soft tissue sarcomas. Cancer 2001;91:1363-71.
20. Heyn R, Haeberlen V, Newton WA, Ragab AH, Raney RB, Tefft M, Wharam M, Ensign LG, Maurer HM. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 1993;11:262-70.
21. Scaradavou A, Heller G, Sklar CA, Ren L, Ghavimi F. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 1995;76:1860-7.
22. Grobmyer SR, Luther N, Antonescu CR, Singer S, Brennan MF. Multiple rimary soft tissue sarcomas. Cancer 2004;101:2633-5.
23. Bisogno G, Sotti G, Nowicki Y, Ferrari A, Garaventa A, Zanetti I, Favre C, Schiavetti A, Tamaro P, Carli M. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group. Cancer 2004;100:1758-65.
24. Hemminki K, Li X. A population-based study of familial soft tissue tumors. J Clin Epidemiol 2001;54:411-6.
25. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer database-updated structure and familial rates. Acta Oncol 2001;40:772-7.
26. Hemminki K, Granstrom C. Risk for familial breast cancer increases with age. Nat Genet 2002;32:233.
27. Hemminki K, Granstrom C, Chen B. The Swedish Family-Cancer Database: update, application to colorectal cancer and clinical relevance. Hereditary Cancer Clin Pract 2005;3:7-18.
28. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer 2001;93:155-61.
29. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000;18:498-509.
30. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Lyon: IARC, 1994.
31. Boice JD, Jr, Storm HH, Curtis RE, Jensen OM, Kleinerman RA, Jensen HS, Flannery JT, Fraumeni JF, Jr. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985;68:3-9.
32. Meadows AT. Second tumours. Eur J Cancer 2001;37:2074-9; discussion. 79-81.
33. de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin MA, Schlienger JY, Shamsaldin A, Diallo I, Bell J, Grimaud E, Hardiman C, Lagrange JL, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999;79:1884-93.
34. Neugut AI, Meadows AT, Robson D. Multiple primary cancers. Philadelphia: Lippincott Williams & Wilkins, 1999.
35. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, Lie SO, Moe PJ, Moller T, Sankila R, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993;307:1030-6.
36. Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, Stovall MA. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer lnst 1996;88:270-8.
37. Cheung MC, Pantanowitz L, Dezube BJ. AlDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 2005;10:412-26.
38. Burns D, Kumar V. The musculoskeletal system. In: Kumar V, Cotran R, Robbins SL, eds. Basic pathology. Pennsylvania: W.B. Saunders, 1997.667-696.
39. Laimer M, Lanschuetzer CM, Hintner H. Interaction between the immune system and tumor cells: cutaneous disorders as a consequence of autoimmunity and immunosuppression. Ann N Y Acad Sci 2004;1028:375-9.
40. Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 2001;85:997-1005.
41. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 2000;136:647-51.
42. Cohen RJ, Curtis RE, lnskip PD, Fraumeni JF, Jr. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005;103:2391-6.
43. Berking C, Brady MS. Cutaneous melanoma in patients with sarcoma. Cancer 1997;79:843-8.
44. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum 1997;70:1-492.
45. Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui CH. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999;354:34-9.